Lilly To Buy ImClone For $6.5B, Tops Bristol Bid
Eli Lilly has formally offered $70 a share for ImClone Systems, topping Bristol-Myers Squibb’s hostile bid of $62 a share. The 6.5 billion deal would be Lilly’s biggest. (Bloomberg)
The Curator finds, summarizes, and links to the highest-quality, most authoritative online sources of business and political news and information: breaking news, analysis, background and opinion. Learn more »
Have something you'd like to share?
Is there an important story you think we should cover or features you would like added? Let us know »
Eli Lilly has formally offered $70 a share for ImClone Systems, topping Bristol-Myers Squibb’s hostile bid of $62 a share. The 6.5 billion deal would be Lilly’s biggest. (Bloomberg)
Categories: Biotech, Pharma · Business & Finance Today
No Comments Yet
You can be the first to comment!
Leave a comment